Literature DB >> 11292839

Development of an inducible pol III transcription system essentially requiring a mutated form of the TATA-binding protein.

W Meissner1, H Rothfels, B Schäfer, K Seifart.   

Abstract

We attempted to devise a transcription system in which a particular DNA sequence of interest could be inducibly expressed under the control of a modified polymerase III (pol III) promoter. Its activation requires a mutated transcription factor not contained endogenously in human cells. We constructed such a promoter by fusing elements of the beta-lactamase gene of Escherichia coli, containing a modified TATA-box and a pol III terminator, to the initiation region of the human U6 gene. This construct functionally resembles a 5'-regulated pol III gene and its transcribed segment can be exchanged for an arbitrary sequence. Its transcription in vitro by pol III requires the same factors as the U6 gene with the major exception that the modified TATA-box of this construct only interacts with a TATA-binding protein (TBP) mutant (TBP-DR2) but not with TBP wild-type (TBPwt). Its transcription therefore requires TBP-DR2 exclusively instead of TBPWT: In order to render the system inducible, we fused the gene coding for TBP-DR2 to a tetracycline control element and stably transfected this new construct into HeLa cells. Induction of such a stable and viable clone with tetracycline resulted in the expression of functional TBP-DR2. This system may conceptually be used in the future to inducibly express an arbitrary DNA sequence in vivo under the control of the above mentioned promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292839      PMCID: PMC31323          DOI: 10.1093/nar/29.8.1672

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

Review 1.  Post-transcriptional gene-silencing: RNAs on the attack or on the defense?

Authors:  T Sijen; J M Kooter
Journal:  Bioessays       Date:  2000-06       Impact factor: 4.345

Review 2.  Double-stranded RNA as a template for gene silencing.

Authors:  B L Bass
Journal:  Cell       Date:  2000-04-28       Impact factor: 41.582

Review 3.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.

Authors:  D Mohuczy; M I Phillips
Journal:  Methods       Date:  2000-11       Impact factor: 3.608

5.  Functional interchangeability of TFIIIB components from yeast and human cells in vitro.

Authors:  M Teichmann; G Dieci; J Huet; J Rüth; A Sentenac; K H Seifart
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

6.  A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.

Authors:  S Freundlieb; C Schirra-Müller; H Bujard
Journal:  J Gene Med       Date:  1999 Jan-Feb       Impact factor: 4.565

7.  Alpha-amanitin, a specific inhibitor of transcription by mammalian RNA-polymerase.

Authors:  K H Seifart; C E Sekeris
Journal:  Z Naturforsch B       Date:  1969-12       Impact factor: 1.047

8.  Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose.

Authors:  J Kyhse-Andersen
Journal:  J Biochem Biophys Methods       Date:  1984-12

9.  Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates.

Authors:  P A Weil; J Segall; B Harris; S Y Ng; R G Roeder
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

10.  The activity binding to the termination region of several pol III genes represents a separate entity and is distinct from a novel component enhancing U6 snRNA transcription.

Authors:  S Oettel; I Kober; K H Seifart
Journal:  Nucleic Acids Res       Date:  1998-10-01       Impact factor: 16.971

View more
  2 in total

1.  Inducible, reversible, and stable RNA interference in mammalian cells.

Authors:  Sunita Gupta; Rebecca A Schoer; James E Egan; Gregory J Hannon; Vivek Mittal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

Review 2.  Antiviral applications of RNAi.

Authors:  K V Morris; J J Rossi
Journal:  Handb Exp Pharmacol       Date:  2006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.